sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells

Cancer Research

Volumn 57, Issue 5, 1997, Pages 956-962

  Delesque, Nathalie ^a   Buscail, Louis ^a   Estève, Jean Pierre ^a   Saint Laurent, Nathalie ^a   Müller, Catherine ^b   Weckbecker, Gisbert ^c   Bruns, Christian ^c   Vaysse, Nicole ^a   Susini, Christiane ^a  

^a CHU RANGUEIL   (France)

^b CNRS   (France)

^c Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ARTICLE; CARCINOGENICITY; CLONOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; RNA, NEOPLASM; SOMATOSTATIN; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031025637     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lewin, M. J. M. The somatostatin receptors in the GI tract. Annu. Rev. Physiol., 54: 455-469, 1992.
2. Schally, A. V. Oncological applications of somatostatin analogues. Cancer Res., 48: 6977-6985, 1988.
3. Weckbecker, G., Raulf, F., Stolz, B., and Bruns, C. Somatoslatin analogs for diagnosis and treatment of cancer. Pharmacol. & Ther., 60: 245-260, 1993.
4. Bell, G. I., and Reisine, T. Molecular biology of somatostatin receptors. Trends Neurosci., 16: 34-38, 1993.
5. Hoyer, D., Bell, G. I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P. P. A., O'Carroll, A-M., Patel, Y. C., Schonbrunn, A., Taylor, J. E., and Reisine, T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci., 16: 86-88, 1995.
6. Buscail, L., Delesque, N., Estève. J-P., Saint-Laurent. N., Prats, H., Clerc, P., Robberecht, P., Bell, G. I., Liebow, C, Schally, A. V., Vaysse, N., and Susini, C. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human receptor subtypes SSTR1 and SSTR2. Proc. Natl. Acad. Sci. USA. 91: 2315-2319, 1994.
7. Buscail, L., Estève. J-P., Saint-Laurent, N., Bertrand, V., Reisine, T., O'Carroll, A-M., Bell, G. I., Schally, A. V., Vaysse, N., and Susini, C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. USA, 92: 1580-1584, 1995.
8. Liebow, C., Reilly, C., Serrano, M. and Schally, A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 86: 2003-2007, 1989.
9. Viguerie, N., Tahiri-Jouti, N., Ayral, A-M., Cambillau, C., Scemama, J-L., Bastié, M-J., Knuhtsen, S., Estève. J-P., Pradayrol, L., Vaysse, N., and Susini, C. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independenl mechanism. Endocrinology, 124: 1017-1025, 1989.
10. Lamberts, S. W. J., Krenning, E. P., and Reubi, J. C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr, Rev., 12: 450-482, 1991.
11. Buscail, L., Saint-Laurent, N., Chastre, E., Vaillant, J. C., Gespach, C., Capellà, G., Kalthoff, H., Lluis, F., Vaysse, N., and Susini, C. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res., 56: 1823-1827, 1996.
12. Klijn, J. G. M., Hoff, A. M., Planting, A. S. T., Verweij, J., Kok, T., Lamberts, S. W. J., Potengen, H., and Foekens, J. A. Treatment of patients with metastalic pancreatic and gastrointestinal tumours with the somatostatin analogue sandostatin: a Phase II study including endocrine effects. Br, J. Cancer. 62: 627-630, 1990.
13. Huguier, M., Samana, G., Testart, J., Mauban, S., Fingerhut, A., Nassar, J., Houry, S., Jaeck, D., De Mestier, P., Favre, J. P., Michot, F., Vidrequin, A., Mantion, G., Veyrieres, M., Fourtanier, G., Lointier, P., and Gignoux, M. Treatment of adenocarcinoma of the pancreas with somutostatin and gonadoliberin (luteinizing hormone-releasing hormone). Am, J. Surg., 164: 348-353, 1992.
14. Friess, H., Buchler, M., Beglinger, C., Weber, A., Kunz, J., Fritsch, K., Dennler, H. J., and Beger, H. G. Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer. Pancreas, 8: 540-545, 1993.
15. Knuhtsen, S., Estève, J. P., Bernadet, B., Vaysse, N., and Susini, C. Molecular characterization of the solubilized receptor of somatostatin from rat pancreatic acinar membranes. Biochem. J., 254: 641-647, 1988.
16. Chayvialle, J. A., Miyata, M., Rayford, P. L., and Thompson, J. C. Effect of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide. Gastroenterology, 79: 844-852, 1980.
17. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-cnloroform extraction. Anal. Biochem., 162: 156-159, 1987.
18. Dukas, K., Sarfati, P., Vaysse, N., and Pradayrol, L. Quantification of changes in the expression of multiple genes by simultaneous polymerase chain reactions. Anal. Biochem., 215: 66-72, 1993.
19. Alonso, S., Minty, A., Bourlet, Y., and Buckingham, M. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol., 23: 11-22, 1986.
20. Shen, L. P,. and Rutter, W. J. Sequence of the human somatostatin I gene. Science (Washington DC), 234: 168-170, 1984.
21. Warshaw, A. L., and Fernandez-Del Castillo. C. Pancreatic carcinoma. N. Eng. J. Med., 326: 455-465, 1992.
22. Reubi, J. C., Waser, B., Schaer, J., C., and Markwalder, R. Somatostatin receptors in human prostate and prostate cancer. J. Clin. Endocrinol. & Metab-., 80: 2806-2814, 1995.
23. Nelson, J., Cremin, J. M., and Murphy, R. F. Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostutin and sandostatin. Br. J. Cancer. 59: 739-742, 1989.
24. De Bruine, A. P., de Vries, J. E., Dinjens, W. N. M., Moerkerk, P. T., Van der Linden, E. P. M., Pijls, M. M. J., Ten Kate, J., and Bosman, F. T. Human Caco-2 cells transfected with C-Ha-Ras as a model for endocrine differentiation in the large intestine. Differentiation, 53: 51-60, 1993.
25. Patel, Y., and Galanopoulou, A. Processing and intracellular targeting of prosomatostatin-derived peptides: the role of mammalian endoproteases. Somatostatin and its receptors. Ciba Found. Symp., 190: 26-50, 1995.
26. Rauly, I., Saint-Laurent, N., Delesque, N., Buscail, L., Estève, J. P., Vaysse, N., and Susini, C. Induction of a negative automne loop by expression of SSTR2 somatostatin receptor in NIH-3T3 cells. J. Clin. Invest., 97: 1874-1883, 1996.
27. Ohmura, E., Lkada, M., and Onoda, N. Insulin-like growth factor I and transforming growth factor α as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res., 50: 19-27, 1990.
28. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, Y., Büchler, M. W., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Invest., 90: 1352-1360, 1992.
29. Smith, J, P., Fantaskey, A. P., Liu, G., and Zagon, I. S. Identification of gastrin as a growth peptide in human pancreatic cancer. Am. J. Physiol., 268: R135-R141, 1995.
30. Nègre, F., Fagot-Revurat, P., Bouisson, M., Rehfeld, J. F., Vaysse, N., and Pradayrol, L. Autocrine Stimulation of AR4-2J rat pancreatic tumor cell growth by glycine-extended gastrin. Int. J. Cancer, 66: 653-658, 1996.
31. Berthélémy, P., Buisson, M., Escourrou, J., Vaysse, N., Rumeau, J. L., and Pradayrol, L. Identification of gastrin as a growth peptide in human pancreatic cancer. Ann. Intern. Med., 123: 188-191, 1995.
32. Pellegata, N. S., Sessa, F., Renault, B., Bonato, M., Leoan, B. E., Solcia, E., and Ranzani, G. N. K.-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res., 54: 1556-1460, 1994.
33. Huang, L., Goodrow, T. L., Zhang, S. Y., Klein-Szanto, J. P., Chang, H., and Ruggeri, B. A. Deletion and/or mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res., 56: 1137-1141, 1996.
34. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
35. Yamada, Y., Stoffel, M., Espinosa, R., Xiang, K. S., Seino, M., Seino, S., Le Beau, M. M., and Bell, G. I. Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms. Genomics, 15: 449-452, 1993.
36. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
37. Zhang, C. Y., Yokogoshi, Y., Yoshimoto, K., Fujinaka, Y., Matsumoto, K., and Saito, S. Point mutation of the somatostatin receptor 2 gene in the human small cell lung cancer cell line COR-L103. Biochem. Biophys. Res. Commun., 210: 805-815, 1995.